HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
Approval
Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
HLB Fails to Receive US FDA Approval for Rivoceranib Liver Cancer Treatment
The logo of HLB HLB has failed to secure approval from the U.S. Food and Drug...
